192
Views
20
CrossRef citations to date
0
Altmetric
Letters

Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst

, , , , , , & show all
Pages 78-80 | Accepted 19 Feb 2016, Published online: 21 Apr 2016

References

  • Draeger HT, Assassi S, Sharif R, Gonzalez EB, Harper BE, Arnett FC, et al. Right bundle branch block: a predictor of mortality in early systemic sclerosis. PLoS One 2013;8:e78808.
  • Kostis JB, Seibold JR, Turkevich D, Masi AT, Grau RG, Medsger TA Jr, et al. Prognostic importance of cardiac arrhythmias in systemic sclerosis. Am J Med 1988;84:1007–14.
  • Clemson BS, Miller WR, Luck JC, Feriss JA. Acute myocarditis in fulminant systemic sclerosis. Chest 1992;101:872–4.
  • Carette S, Turcotte J, Mathon G. Severe myositis and myocarditis in progressive systemic sclerosis. J Rheumatol 1985;12:997–9.
  • Kerr LD, Spiera H. Myocarditis as a complication in scleroderma patients with myositis. Clin Cardiol 1993;16:895–9.
  • Stack J, McLaughlin P, Sinnot C, Henry M, MacEneaney P, Eltahir A, et al. Successful control of scleroderma myocarditis using a combination of cyclophosphamide and methylprednisolone. Rheumatology (Oxford) 2000;39:674–9.
  • Stack J, McLaughlin P, Sinnot C, Henry M, Mac Eneaney P, Eltahir A, et al. Successful control of scleroderma myocarditis using a combination of cyclophosphamide and methylprednisolone. Scand J Rheumatol 2010;39:349–50.
  • Mueller KA, Mueller II, Eppler D, Zuern CS, Seizer P, Kramer U, et al. Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy. PLoS One 2015;10:e0126707.
  • Pieroni M, De Santis M, Zizzo G, Bosello S, Smaldone C, Campioni M, et al. Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression. Semin Arthritis Rheum 2014;43:526–35.
  • Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010;69:1809–15.
  • Follansbee WP, Zerbe TR, Medsger Jr. TA, Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association. Am Heart J 1993;125:194–203.
  • Bulkley BH, Ridolfi RL, Salyer WR, Hurchins GM. Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 1976;53:483–90.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.